Skip to main content
Fig. 2 | BMC Oral Health

Fig. 2

From: Changes in salivary oxidative status, salivary cortisol, and clinical symptoms in female patients with temporomandibular disorders during occlusal splint therapy: a 3-month follow up

Fig. 2

ab Visual analogue scale scores (means and standard deviations) during the 3-month interval of occlusal splint therapy. Asterisk indicates a post-hoc significant difference (within group comparisons, compared to baseline). *p < 0.05 **p < 0.001. VAS, Visual Analogue Scale; MP, myofascial pain; DD, disc displacement; HIP, high-intensity pain; LIP, low-intensity pain

Back to article page